16 October 2019
Visiongain has launched a new pharma report ‘’Moist Wound Dressings Market Report 2020-2030’’ by Product (Hydrocolloid Dressings, Foam Dressings, Alginate Dressings, Hydrogel Dressings, Film Dressings, Others), Application (Burn Wounds, Diabetic Ulcer, Pressure Ulcer, Surgical Wounds, Traumatic Wounds, Others), End Users (Homecare, Hospitals, Others), and Geography.
The global moist wound dressings market is anticipated to grow at a lucrative CAGR of 5.9% and anticipated to surpass USD 6.5 Billion by 2030.
A wound dressing is a method designed to safeguard wounds from microbial diseases, necrosis spread, and contamination. Dressing the wound by covering with a wet wound healing bandage enables to enhance wound healing. A wound is triggered by burns, accidents, cuts, scrapes, and causes injury to living tissue. Moist wound dressing offers a moist atmosphere that helps to heal injuries more quickly.
The growing incidence of acute and chronic wounds is driving the worldwide market for moist wound dressings. Acute injuries such as surgical injuries, traumatic injuries, chronic wounds, and pressure ulcers are increasing globally. Patients with first and second-degree burns, pressure ulcers, and diabetic ulcers are among the largest number of stays in hospitals in multiple healthcare environments worldwide. This increases demand for moist wound dressings as it guarantees quicker wound healing, improves autolytic debridement, and decreases the risk of wound infection.
Also, launching novel therapies such as electromagnetic treatment, electrical stimulation, nanotechnology, and using silver and other combination dressings is anticipated to boost market development. These advances guarantee better care for the wound and thus boost the acceptance of the product. The capacity of these dressings to control moisture at the wound site, which helps in tissue regeneration and decreased infection and pain, is one of the significant industry advances. Advanced products promote wound safety, protection against bacteria, thermal insulation, absorption of exudates, and more; thus, boosting the market growth.
Developing adequate reimbursement strategies is a growing trend in developed countries, resulting in a growing number of local market players. Increasing government initiatives for awareness of therapy in both advanced and developing nations serve as a significant chance for market leader having a global presence.
North America retains most of the market share followed by Europe and will continue to dominate in the future as a consequence of target population base presence and enhanced patient consciousness. Due to growing cases of chronic wounds in the region, such as diabetic foot and pressure ulcers, the market is projected to grow further. According to the CDC, in the United States, around 2.5 million patients suffer from pressure ulcers every year. Also, the factors contributing to the growth of the regional moist wound dressing market is the accessibility of products due to the existence of significant market players and their broad distribution network.
Growing demographics and economies are anticipated to stimulate market growth in the Asia Pacific region especially in emerging nations such as China, Japan, and India. Furthermore, advancements in wound care products and techniques, increasing technology acceptance and growing patient awareness are anticipated to offer fresh possibilities for regional growth.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products to strengthen their position in the global moist wound dressings market. Companies are also escalating their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the market.
The comprehensive market report features companies such as Acelity L.P., Inc., 3M, BSN Medical GmbH, Cardinal Health, B. Braun Melsungen AG, Coloplast A/S, Derma Sciences, Inc., Hollister Incorporated, Integra LifeSciences Holdings Corporation, ConvaTec, Inc., Laboratoires URGO, Medtronic, Medline Industries, Inc., Molnlycke Health Care AB, Smith & Nephew plc. and Systagenix among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020–2030 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.